ECCU (E-cadherin/catenin) complex and its role in carcinogenesis
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.074Keywords
E-cadherin, catenin, ECCU complex, carcinogenesis, adhesionAbstract
Introduction:
One of the main characteristics of cancer is uncontrolled cell proliferation as well as loss of cells adhesion in the case of metastases. Cadherins and catenins are the molecules responsible for cell-to-cell interaction. Together, they form a complex called ECCU (E-cadherin/catenin complex) which maintains the proper tissue structure. However, an impairment in its functioning can result in many adverse health effects, such as cancer promotion.
Purpose:
To evaluate the potential role of ECCU complex in carcinogenesis.
Materials and methods:
We performed the database research using PubMed, Springer Link and ResearchGate and we made review and meta-analysis of relevant studies. We searched for studies analyzing the relationship between ECCU complex and carcinomas development.
Results:
ECCU takes part in many cell processes and pathways, such as Wnt/Wingless‐signaling pathway or EMT/MET processes. It interacts with various molecules, for instance p27 protein or transcription factors. Aberrations in the expression of ECCU components is related to carcinoma promotion, shorter survival rate of patients and poor differentiation of the tumor.
Conclusions:
A role of the ECCU complex is complicated, however there is a clear correlation between loss of cell adhesion and carcinoma promotion and progression. The complex can be a possible target of anti-cancer therapy in the future; it is also under investigations as a marker of the disease, however it is questionable.
References
Peters JM, Gonzalez FJ. The Evolution of Carcinogenesis. Toxicol Sci. 2018;165(2):272-276. doi:10.1093/toxsci/kfy184
Sheng L, Leshchyns’ka I, Sytnyk V. Cell adhesion and intracellular calcium signaling in neurons. Cell Commun Signal. 2013;11:94.
Kemler R. Classical cadherins. Semin Cell Biol. 1992;3(3):149-155. doi:10.1016/s1043-4682(10)80011-x
Sano, K., Tanihara, H., Heimark, R. L., Obata, S., Davidson, M., St John, T., Taketani, S., & Suzuki, S. (1993). Protocadherins: a large family of cadherin-related molecules in central nervous system. The EMBO journal, 12(6), 2249–2256.
Bruner HC, Derksen PWB. Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer. Cold Spring Harb Perspect Biol. 2018;10(3):a029330. Published 2018 Mar 1. doi:10.1101/cshperspect.a029330
Shang, Shuang & Hua, Fang & Hu, Zhuo-Wei. (2015). The regulation of β-catenin activity and function in cancer: Therapeutic opportunities. Oncotarget. 8. 10.18632/oncotarget.15687.
Kowalczyk AP, Reynolds AB. Protecting your tail: regulation of cadherin degradation by p120-catenin. Curr Opin Cell Biol. 2004;16:522–527.
Berx G, Nollet F, van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun. 1998;6(2-3):171-184. doi:10.3109/15419069809004474
Zhang X, Yang M, Shi H, et al. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation. Oncotarget. 2017;8(12):19566-19576. doi:10.18632/oncotarget.15361
Selaru FM, David S, Meltzer SJ, Hamilton JP. Epigenetic events in gastrointestinal cancer. The American Journal of Gastroenterology. 2009 Aug;104(8):1910-1912. DOI: 10.1038/ajg.2008.145
Figueiredo J, Melo S, Carneiro P, et al. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56(4):199-208. doi:10.1136/jmedgenet-2018-105807
Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61(9):3819-3825.
Currier, A. W., Kolb, E. A., Gorlick, R. G., Roth, M. E., Gopalakrishnan, V., & Sampson, V. B. (2019). p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma. Scientific reports, 9(1), 6161. https://doi.org/10.1038/s41598-019-42450-0
Bourguignon LY, Gunja-Smith Z, Iida N, et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998;176(1):206-215. doi:10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3
Mao, M., Zheng, X., Jin, B., Zhang, F., Zhu, L., & Cui, L. (2017). Effects of CD44 and E cadherin overexpression on the proliferation, adhesion and invasion of ovarian cancer cells. Experimental and Therapeutic Medicine, 14, 5557-5563. https://doi.org/10.3892/etm.2017.5259
Le Bras, G. F., Allison, G. L., Richards, N. F., Ansari, S. S., Washington, M. K., & Andl, C. D. (2011). CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. PloS one, 6(11), e27063. https://doi.org/10.1371/journal.pone.0027063
van Ooyen A, Nusse R. Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell. 1984;39:233–240.
Wierstra I, Alves J. The c-myc promoter: still MysterY and challenge. Adv Cancer Res. 2008;99:113-333. doi:10.1016/S0065-230X(07)99004-1
Damsky WE, Curley DP, Santhanakrishnan M, et al. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell. 2011;20(6):741-754. doi:10.1016/j.ccr.2011.10.030
Kobayashi M, Honma T, Matsuda Y, et al. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer. 2000;82(10):1689-1693. doi:10.1054/bjoc.1999.1112
Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422-426. doi:10.1038/18884
Alamoud KA, Kukuruzinska MA. Emerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer. J Dent Res. 2018;97(6):665-673. doi:10.1177/0022034518771923
Wang, B., Li, X., Liu, L. et al. β-Catenin: oncogenic role and therapeutic target in cervical cancer. Biol Res 53, 33 (2020). https://doi.org/10.1186/s40659-020-00301-7
Wiseman SM, Masoudi H, Niblock P, et al. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg. 2006;191(5):581-587. doi:10.1016/j.amjsurg.2006.02.005
Dihlmann S, Siermann A, von Knebel Doeberitz M. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene. 2001;20(5):645–53.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 546
Number of citations: 0